These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30346082)

  • 1. The antitumour growth and antiangiogenesis effects of xanthatin in murine glioma dynamically evaluated by dynamic contrast-enhanced magnetic resonance imaging.
    Bi SX; Li XH; Wei CS; Xiang HH; Shen YX; Yu YQ
    Phytother Res; 2019 Jan; 33(1):149-158. PubMed ID: 30346082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthatin induces glioma cell apoptosis and inhibits tumor growth via activating endoplasmic reticulum stress-dependent CHOP pathway.
    Ma YY; Di ZM; Cao Q; Xu WS; Bi SX; Yu JS; Shen YJ; Yu YQ; Shen YX; Feng LJ
    Acta Pharmacol Sin; 2020 Mar; 41(3):404-414. PubMed ID: 31700088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.
    Xuesong D; Wei X; Heng L; Xiao C; Shunan W; Yu G; Weiguo Z
    Acta Radiol; 2017 Sep; 58(9):1138-1146. PubMed ID: 27956462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced magnetic resonance imaging for monitoring the anti-angiogenesis efficacy in a C6 glioma rat model.
    Hou W; Li X; Pan H; Xu M; Bi S; Shen Y; Yu Y
    Acta Radiol; 2020 Jul; 61(7):973-982. PubMed ID: 31739674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
    NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of xanthatin: anticancer properties and mechanisms of inhibited murine melanoma in vitro and in vivo.
    Li WD; Wu Y; Zhang L; Yan LG; Yin FZ; Ruan JS; Chen ZP; Yang GM; Yan CP; Zhao D; Lu Y; Cai BC
    Phytomedicine; 2013 Jul; 20(10):865-73. PubMed ID: 23664560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopy.
    Dominietto M; Dobosz M; Bürgi S; Renner A; Zahlmann G; Scheuer W; Rudin M
    Eur Radiol; 2017 Jul; 27(7):2894-2902. PubMed ID: 27830379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model.
    Hoff BA; Bhojani MS; Rudge J; Chenevert TL; Meyer CR; Galbán S; Johnson TD; Leopold JS; Rehemtulla A; Ross BD; Galbán CJ
    NMR Biomed; 2012 Jul; 25(7):935-42. PubMed ID: 22190279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.
    Sun C; Yu Y; Wang L; Wu B; Xia L; Feng F; Ling Z; Wang S
    J Exp Clin Cancer Res; 2016 Feb; 35():32. PubMed ID: 26872471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
    Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
    Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
    Beaumont M; Lemasson B; Farion R; Segebarth C; Rémy C; Barbier EL
    J Cereb Blood Flow Metab; 2009 Oct; 29(10):1714-26. PubMed ID: 19584891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative in vivo imaging of tissue factor expression in glioma using dynamic contrast-enhanced MRI derived parameters.
    Chen X; Xie T; Fang J; Xue W; Tong H; Kang H; Wang S; Yang Y; Xu M; Zhang W
    Eur J Radiol; 2017 Aug; 93():236-242. PubMed ID: 28668420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
    Li Y; Liu G; Lou X; Chen Z; Ma L
    Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting.
    Hamans B; Navis AC; Wright A; Wesseling P; Heerschap A; Leenders W
    Neuro Oncol; 2013 Dec; 15(12):1615-24. PubMed ID: 24158109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
    Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma model.
    Luo Y; Jiang F; Cole TB; Hradil VP; Reuter D; Chakravartty A; Albert DH; Davidsen SK; Cox BF; McKeegan EM; Fox GB
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):911-21. PubMed ID: 22080168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?
    Little RA; Barjat H; Hare JI; Jenner M; Watson Y; Cheung S; Holliday K; Zhang W; O'Connor JPB; Barry ST; Puri S; Parker GJM; Waterton JC
    Magn Reson Imaging; 2018 Feb; 46():98-105. PubMed ID: 29154898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.